nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Tamoxifen—pancreatic cancer	0.0671	0.108	CbGbCtD
Oxybutynin—CYP2C8—Tamoxifen—pancreatic cancer	0.0645	0.104	CbGbCtD
Oxybutynin—CYP3A5—Erlotinib—pancreatic cancer	0.0571	0.092	CbGbCtD
Oxybutynin—CYP2C8—Erlotinib—pancreatic cancer	0.0549	0.0885	CbGbCtD
Oxybutynin—CYP3A5—Irinotecan—pancreatic cancer	0.0515	0.0831	CbGbCtD
Oxybutynin—CYP2C8—Fluorouracil—pancreatic cancer	0.0476	0.0767	CbGbCtD
Oxybutynin—CYP2D6—Tamoxifen—pancreatic cancer	0.0412	0.0663	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—pancreatic cancer	0.0378	0.0609	CbGbCtD
Oxybutynin—CYP3A5—Sunitinib—pancreatic cancer	0.0376	0.0606	CbGbCtD
Oxybutynin—CYP2D6—Erlotinib—pancreatic cancer	0.035	0.0564	CbGbCtD
Oxybutynin—CYP3A4—Tamoxifen—pancreatic cancer	0.0262	0.0422	CbGbCtD
Oxybutynin—CYP3A4—Erlotinib—pancreatic cancer	0.0223	0.0359	CbGbCtD
Oxybutynin—CYP3A4—Irinotecan—pancreatic cancer	0.0201	0.0324	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—pancreatic cancer	0.0173	0.0278	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—pancreatic cancer	0.0147	0.0237	CbGbCtD
Oxybutynin—CYP3A4—Sunitinib—pancreatic cancer	0.0147	0.0236	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—pancreatic cancer	0.011	0.0177	CbGbCtD
Oxybutynin—Vomiting—Sunitinib—pancreatic cancer	0.000224	0.000736	CcSEcCtD
Oxybutynin—Dysuria—Epirubicin—pancreatic cancer	0.000223	0.000731	CcSEcCtD
Oxybutynin—Rash—Sunitinib—pancreatic cancer	0.000222	0.00073	CcSEcCtD
Oxybutynin—Dermatitis—Sunitinib—pancreatic cancer	0.000222	0.000729	CcSEcCtD
Oxybutynin—Abdominal distension—Doxorubicin—pancreatic cancer	0.000222	0.000728	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000221	0.000727	CcSEcCtD
Oxybutynin—Urticaria—Fluorouracil—pancreatic cancer	0.000221	0.000725	CcSEcCtD
Oxybutynin—Headache—Sunitinib—pancreatic cancer	0.000221	0.000725	CcSEcCtD
Oxybutynin—Syncope—Docetaxel—pancreatic cancer	0.000221	0.000724	CcSEcCtD
Oxybutynin—Influenza—Doxorubicin—pancreatic cancer	0.00022	0.000723	CcSEcCtD
Oxybutynin—Asthma—Doxorubicin—pancreatic cancer	0.00022	0.000723	CcSEcCtD
Oxybutynin—Dysphagia—Doxorubicin—pancreatic cancer	0.00022	0.000723	CcSEcCtD
Oxybutynin—Pollakiuria—Epirubicin—pancreatic cancer	0.00022	0.000722	CcSEcCtD
Oxybutynin—Palpitations—Docetaxel—pancreatic cancer	0.000218	0.000714	CcSEcCtD
Oxybutynin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000216	0.00071	CcSEcCtD
Oxybutynin—Cough—Docetaxel—pancreatic cancer	0.000215	0.000705	CcSEcCtD
Oxybutynin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000214	0.000702	CcSEcCtD
Oxybutynin—Convulsion—Docetaxel—pancreatic cancer	0.000213	0.0007	CcSEcCtD
Oxybutynin—Hypertension—Docetaxel—pancreatic cancer	0.000213	0.000697	CcSEcCtD
Oxybutynin—Infestation—Epirubicin—pancreatic cancer	0.000212	0.000697	CcSEcCtD
Oxybutynin—Infestation NOS—Epirubicin—pancreatic cancer	0.000212	0.000697	CcSEcCtD
Oxybutynin—Drowsiness—Epirubicin—pancreatic cancer	0.000212	0.000697	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—pancreatic cancer	0.000212	0.000696	CcSEcCtD
Oxybutynin—Arthralgia—Docetaxel—pancreatic cancer	0.00021	0.000688	CcSEcCtD
Oxybutynin—Chest pain—Docetaxel—pancreatic cancer	0.00021	0.000688	CcSEcCtD
Oxybutynin—Nausea—Sunitinib—pancreatic cancer	0.00021	0.000688	CcSEcCtD
Oxybutynin—Asthenia—Irinotecan—pancreatic cancer	0.000209	0.000684	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000208	0.000683	CcSEcCtD
Oxybutynin—Stomatitis—Epirubicin—pancreatic cancer	0.000207	0.000679	CcSEcCtD
Oxybutynin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000207	0.000678	CcSEcCtD
Oxybutynin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000207	0.000678	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—pancreatic cancer	0.000206	0.000676	CcSEcCtD
Oxybutynin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000205	0.000673	CcSEcCtD
Oxybutynin—Dry mouth—Docetaxel—pancreatic cancer	0.000205	0.000672	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000205	0.000672	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000204	0.000668	CcSEcCtD
Oxybutynin—Asthenia—Gemcitabine—pancreatic cancer	0.000203	0.000666	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—pancreatic cancer	0.000203	0.000665	CcSEcCtD
Oxybutynin—Confusional state—Docetaxel—pancreatic cancer	0.000203	0.000665	CcSEcCtD
Oxybutynin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000201	0.000659	CcSEcCtD
Oxybutynin—Oedema—Docetaxel—pancreatic cancer	0.000201	0.000659	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—pancreatic cancer	0.0002	0.000657	CcSEcCtD
Oxybutynin—Pruritus—Gemcitabine—pancreatic cancer	0.0002	0.000657	CcSEcCtD
Oxybutynin—Infection—Docetaxel—pancreatic cancer	0.0002	0.000655	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—pancreatic cancer	0.000199	0.000654	CcSEcCtD
Oxybutynin—Diarrhoea—Irinotecan—pancreatic cancer	0.000199	0.000652	CcSEcCtD
Oxybutynin—Shock—Docetaxel—pancreatic cancer	0.000198	0.000648	CcSEcCtD
Oxybutynin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000197	0.000646	CcSEcCtD
Oxybutynin—Pruritus—Fluorouracil—pancreatic cancer	0.000197	0.000646	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000197	0.000645	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—pancreatic cancer	0.000197	0.000645	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—pancreatic cancer	0.000197	0.000645	CcSEcCtD
Oxybutynin—Tachycardia—Docetaxel—pancreatic cancer	0.000196	0.000643	CcSEcCtD
Oxybutynin—Skin disorder—Docetaxel—pancreatic cancer	0.000195	0.00064	CcSEcCtD
Oxybutynin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000194	0.000635	CcSEcCtD
Oxybutynin—Dizziness—Irinotecan—pancreatic cancer	0.000192	0.00063	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—pancreatic cancer	0.000192	0.000629	CcSEcCtD
Oxybutynin—Anorexia—Docetaxel—pancreatic cancer	0.000191	0.000628	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—pancreatic cancer	0.000191	0.000627	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000191	0.000627	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000191	0.000627	CcSEcCtD
Oxybutynin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00019	0.000625	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00019	0.000623	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—pancreatic cancer	0.000189	0.000621	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000188	0.000618	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000188	0.000616	CcSEcCtD
Oxybutynin—Hypotension—Docetaxel—pancreatic cancer	0.000188	0.000616	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—pancreatic cancer	0.000187	0.000615	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000187	0.000615	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—pancreatic cancer	0.000187	0.000613	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—pancreatic cancer	0.000185	0.000608	CcSEcCtD
Oxybutynin—Vomiting—Irinotecan—pancreatic cancer	0.000185	0.000606	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—pancreatic cancer	0.000184	0.000605	CcSEcCtD
Oxybutynin—Dizziness—Fluorouracil—pancreatic cancer	0.000184	0.000604	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—pancreatic cancer	0.000184	0.000603	CcSEcCtD
Oxybutynin—Rash—Irinotecan—pancreatic cancer	0.000183	0.000601	CcSEcCtD
Oxybutynin—Dermatitis—Irinotecan—pancreatic cancer	0.000183	0.000601	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000183	0.0006	CcSEcCtD
Oxybutynin—Headache—Irinotecan—pancreatic cancer	0.000182	0.000597	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—pancreatic cancer	0.000182	0.000596	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—pancreatic cancer	0.00018	0.000592	CcSEcCtD
Oxybutynin—Vomiting—Gemcitabine—pancreatic cancer	0.00018	0.000591	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—pancreatic cancer	0.000179	0.000586	CcSEcCtD
Oxybutynin—Rash—Gemcitabine—pancreatic cancer	0.000178	0.000586	CcSEcCtD
Oxybutynin—Dermatitis—Gemcitabine—pancreatic cancer	0.000178	0.000585	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—pancreatic cancer	0.000178	0.000585	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—pancreatic cancer	0.000178	0.000583	CcSEcCtD
Oxybutynin—Headache—Gemcitabine—pancreatic cancer	0.000177	0.000582	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—pancreatic cancer	0.000177	0.000581	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000177	0.000581	CcSEcCtD
Oxybutynin—Vomiting—Fluorouracil—pancreatic cancer	0.000177	0.000581	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—pancreatic cancer	0.000177	0.00058	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—pancreatic cancer	0.000177	0.00058	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000176	0.000576	CcSEcCtD
Oxybutynin—Rash—Fluorouracil—pancreatic cancer	0.000175	0.000576	CcSEcCtD
Oxybutynin—Dermatitis—Fluorouracil—pancreatic cancer	0.000175	0.000575	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000175	0.000575	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—pancreatic cancer	0.000175	0.000573	CcSEcCtD
Oxybutynin—Headache—Fluorouracil—pancreatic cancer	0.000174	0.000572	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000174	0.000572	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000174	0.00057	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000173	0.000569	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000173	0.000569	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—pancreatic cancer	0.000173	0.000568	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—pancreatic cancer	0.000173	0.000568	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000173	0.000568	CcSEcCtD
Oxybutynin—Nausea—Irinotecan—pancreatic cancer	0.000173	0.000566	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000172	0.000564	CcSEcCtD
Oxybutynin—Pain—Docetaxel—pancreatic cancer	0.000172	0.000564	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—pancreatic cancer	0.000172	0.000564	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—pancreatic cancer	0.00017	0.000559	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—pancreatic cancer	0.00017	0.000558	CcSEcCtD
Oxybutynin—Nausea—Gemcitabine—pancreatic cancer	0.000168	0.000552	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—pancreatic cancer	0.000167	0.000548	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—pancreatic cancer	0.000166	0.000545	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—pancreatic cancer	0.000166	0.000545	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000166	0.000543	CcSEcCtD
Oxybutynin—Nausea—Fluorouracil—pancreatic cancer	0.000165	0.000542	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—pancreatic cancer	0.000165	0.000541	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—pancreatic cancer	0.000165	0.00054	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000164	0.000539	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000164	0.000537	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—pancreatic cancer	0.000164	0.000537	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—pancreatic cancer	0.000164	0.000537	CcSEcCtD
Oxybutynin—Tension—Epirubicin—pancreatic cancer	0.000163	0.000535	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—pancreatic cancer	0.000163	0.000533	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—pancreatic cancer	0.000161	0.000529	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—pancreatic cancer	0.000161	0.000527	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—pancreatic cancer	0.00016	0.000525	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000159	0.000522	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—pancreatic cancer	0.000159	0.000521	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000158	0.000517	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—pancreatic cancer	0.000156	0.000513	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—pancreatic cancer	0.000155	0.000507	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000154	0.000505	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—pancreatic cancer	0.000154	0.000504	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—pancreatic cancer	0.000154	0.000504	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—pancreatic cancer	0.000153	0.000501	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—pancreatic cancer	0.000151	0.000497	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—pancreatic cancer	0.000151	0.000495	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—pancreatic cancer	0.00015	0.000494	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—pancreatic cancer	0.00015	0.000491	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—pancreatic cancer	0.000149	0.00049	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—pancreatic cancer	0.000149	0.000488	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—pancreatic cancer	0.000149	0.000488	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000148	0.000486	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—pancreatic cancer	0.000147	0.000481	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000146	0.000479	CcSEcCtD
Oxybutynin—Cough—Epirubicin—pancreatic cancer	0.000145	0.000475	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—pancreatic cancer	0.000145	0.000475	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—pancreatic cancer	0.000144	0.000473	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—pancreatic cancer	0.000144	0.000472	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—pancreatic cancer	0.000143	0.00047	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000143	0.000468	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—pancreatic cancer	0.000142	0.000466	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—pancreatic cancer	0.000141	0.000464	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—pancreatic cancer	0.000141	0.000464	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—pancreatic cancer	0.000141	0.000463	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—pancreatic cancer	0.000141	0.000462	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00014	0.000461	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—pancreatic cancer	0.00014	0.000458	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—pancreatic cancer	0.000139	0.000455	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—pancreatic cancer	0.000138	0.000454	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—pancreatic cancer	0.000138	0.000452	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—pancreatic cancer	0.000137	0.000451	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—pancreatic cancer	0.000137	0.000448	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—pancreatic cancer	0.000136	0.000445	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000136	0.000445	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—pancreatic cancer	0.000136	0.000445	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000135	0.000443	CcSEcCtD
Oxybutynin—Infection—Epirubicin—pancreatic cancer	0.000135	0.000442	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—pancreatic cancer	0.000134	0.00044	CcSEcCtD
Oxybutynin—Shock—Epirubicin—pancreatic cancer	0.000133	0.000437	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—pancreatic cancer	0.000133	0.000437	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000133	0.000436	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—pancreatic cancer	0.000133	0.000436	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—pancreatic cancer	0.000133	0.000435	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—pancreatic cancer	0.000132	0.000434	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—pancreatic cancer	0.000132	0.000432	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—pancreatic cancer	0.000131	0.000429	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—pancreatic cancer	0.000131	0.000429	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—pancreatic cancer	0.00013	0.000428	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00013	0.000426	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—pancreatic cancer	0.000129	0.000424	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—pancreatic cancer	0.000129	0.000424	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—pancreatic cancer	0.000128	0.00042	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—pancreatic cancer	0.000128	0.000419	CcSEcCtD
Oxybutynin—Rash—Docetaxel—pancreatic cancer	0.000127	0.000416	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—pancreatic cancer	0.000127	0.000415	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—pancreatic cancer	0.000127	0.000415	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—pancreatic cancer	0.000126	0.000415	CcSEcCtD
Oxybutynin—Headache—Docetaxel—pancreatic cancer	0.000126	0.000413	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000125	0.000411	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—pancreatic cancer	0.000125	0.000411	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—pancreatic cancer	0.000125	0.000409	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000123	0.000405	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—pancreatic cancer	0.000123	0.000405	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000123	0.000403	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—pancreatic cancer	0.000123	0.000402	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—pancreatic cancer	0.000122	0.000401	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—pancreatic cancer	0.000122	0.0004	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—pancreatic cancer	0.000122	0.000399	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—pancreatic cancer	0.00012	0.000395	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—pancreatic cancer	0.00012	0.000392	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—pancreatic cancer	0.000119	0.000391	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—pancreatic cancer	0.000119	0.000391	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—pancreatic cancer	0.000118	0.000386	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—pancreatic cancer	0.000117	0.000384	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000117	0.000384	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—pancreatic cancer	0.000117	0.000383	CcSEcCtD
Oxybutynin—Pain—Epirubicin—pancreatic cancer	0.000116	0.00038	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—pancreatic cancer	0.000116	0.00038	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000114	0.000375	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—pancreatic cancer	0.000113	0.000372	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000113	0.000369	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000112	0.000366	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—pancreatic cancer	0.000111	0.000366	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000111	0.000364	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—pancreatic cancer	0.00011	0.000362	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000109	0.000358	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000108	0.000355	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—pancreatic cancer	0.000108	0.000355	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—pancreatic cancer	0.000108	0.000353	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—pancreatic cancer	0.000107	0.000352	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—pancreatic cancer	0.000107	0.000352	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—pancreatic cancer	0.000107	0.000351	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000103	0.000339	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000103	0.000336	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—pancreatic cancer	9.98e-05	0.000328	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—pancreatic cancer	9.96e-05	0.000327	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—pancreatic cancer	9.91e-05	0.000325	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—pancreatic cancer	9.72e-05	0.000319	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—pancreatic cancer	9.59e-05	0.000315	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—pancreatic cancer	9.27e-05	0.000304	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—pancreatic cancer	9.24e-05	0.000303	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—pancreatic cancer	9e-05	0.000295	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—pancreatic cancer	8.96e-05	0.000294	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—pancreatic cancer	8.87e-05	0.000291	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—pancreatic cancer	8.62e-05	0.000283	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—pancreatic cancer	8.58e-05	0.000281	CcSEcCtD
Oxybutynin—Rash—Epirubicin—pancreatic cancer	8.54e-05	0.00028	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—pancreatic cancer	8.54e-05	0.00028	CcSEcCtD
Oxybutynin—Headache—Epirubicin—pancreatic cancer	8.49e-05	0.000278	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—pancreatic cancer	8.29e-05	0.000272	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—pancreatic cancer	8.05e-05	0.000264	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—pancreatic cancer	7.97e-05	0.000262	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—pancreatic cancer	7.91e-05	0.000259	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—pancreatic cancer	7.9e-05	0.000259	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—pancreatic cancer	7.85e-05	0.000258	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—pancreatic cancer	7.45e-05	0.000244	CcSEcCtD
Oxybutynin—CHRM3—Signaling Pathways—GCG—pancreatic cancer	2.08e-05	0.000278	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.07e-05	0.000276	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—GCG—pancreatic cancer	2.06e-05	0.000275	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.03e-05	0.000271	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.02e-05	0.00027	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—TYMS—pancreatic cancer	2.01e-05	0.000269	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2e-05	0.000268	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2e-05	0.000268	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	1.99e-05	0.000267	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	1.99e-05	0.000266	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.99e-05	0.000266	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	1.99e-05	0.000266	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	1.98e-05	0.000265	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—STK11—pancreatic cancer	1.96e-05	0.000263	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.96e-05	0.000262	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STK11—pancreatic cancer	1.96e-05	0.000262	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STK11—pancreatic cancer	1.95e-05	0.000261	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—APOE—pancreatic cancer	1.95e-05	0.00026	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STK11—pancreatic cancer	1.93e-05	0.000259	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KDR—pancreatic cancer	1.91e-05	0.000255	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CD44—pancreatic cancer	1.89e-05	0.000252	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.85e-05	0.000247	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.84e-05	0.000246	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	1.83e-05	0.000245	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.83e-05	0.000245	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.82e-05	0.000243	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	1.81e-05	0.000243	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GCG—pancreatic cancer	1.81e-05	0.000242	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	1.8e-05	0.00024	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.77e-05	0.000236	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.76e-05	0.000236	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	1.76e-05	0.000235	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	1.76e-05	0.000235	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.74e-05	0.000233	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.74e-05	0.000232	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGF—pancreatic cancer	1.74e-05	0.000232	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.72e-05	0.000229	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	1.71e-05	0.000229	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—STK11—pancreatic cancer	1.7e-05	0.000227	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.7e-05	0.000227	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	1.69e-05	0.000227	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	1.69e-05	0.000226	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.69e-05	0.000226	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.68e-05	0.000224	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HES1—pancreatic cancer	1.67e-05	0.000224	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HES1—pancreatic cancer	1.67e-05	0.000223	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HES1—pancreatic cancer	1.65e-05	0.000221	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—APOE—pancreatic cancer	1.63e-05	0.000218	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.6e-05	0.000215	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	1.6e-05	0.000214	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	1.6e-05	0.000214	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.6e-05	0.000214	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.58e-05	0.000212	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CD44—pancreatic cancer	1.55e-05	0.000207	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	1.54e-05	0.000207	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	1.54e-05	0.000206	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	1.54e-05	0.000206	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.53e-05	0.000205	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.52e-05	0.000204	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	1.51e-05	0.000202	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GCG—pancreatic cancer	1.48e-05	0.000199	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CG—pancreatic cancer	1.47e-05	0.000197	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TERT—pancreatic cancer	1.47e-05	0.000196	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TERT—pancreatic cancer	1.46e-05	0.000196	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.46e-05	0.000196	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.45e-05	0.000194	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—pancreatic cancer	1.42e-05	0.00019	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.4e-05	0.000188	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.4e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	1.4e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	1.4e-05	0.000187	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—STK11—pancreatic cancer	1.4e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	1.4e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	1.39e-05	0.000186	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.39e-05	0.000185	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.38e-05	0.000185	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.38e-05	0.000184	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOE—pancreatic cancer	1.37e-05	0.000184	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOE—pancreatic cancer	1.37e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOE—pancreatic cancer	1.37e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.35e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	1.35e-05	0.00018	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—pancreatic cancer	1.34e-05	0.00018	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—pancreatic cancer	1.34e-05	0.000179	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.33e-05	0.000177	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.31e-05	0.000175	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CD—pancreatic cancer	1.3e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	1.29e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	1.28e-05	0.000172	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.28e-05	0.000171	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	1.27e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.26e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	1.26e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.26e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	1.25e-05	0.000167	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.25e-05	0.000167	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.24e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	1.24e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.24e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.24e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	1.23e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	1.23e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.21e-05	0.000161	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	1.2e-05	0.000161	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.2e-05	0.000161	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.2e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	1.19e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOE—pancreatic cancer	1.19e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	1.17e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	1.16e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	1.13e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.13e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.13e-05	0.000151	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.13e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.12e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.12e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.11e-05	0.000149	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.09e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.08e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—pancreatic cancer	1.08e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.08e-05	0.000144	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.07e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.07e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.07e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.06e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.05e-05	0.000141	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	1.05e-05	0.00014	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	1.04e-05	0.000139	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	1.04e-05	0.000139	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.04e-05	0.000139	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CD44—pancreatic cancer	1.01e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.78e-06	0.000131	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOE—pancreatic cancer	9.77e-06	0.000131	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—pancreatic cancer	9.76e-06	0.000131	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	9.75e-06	0.00013	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCG—pancreatic cancer	9.71e-06	0.00013	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—pancreatic cancer	9.66e-06	0.000129	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.65e-06	0.000129	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	9.64e-06	0.000129	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	9.5e-06	0.000127	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	9.47e-06	0.000127	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	9.45e-06	0.000126	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	9.44e-06	0.000126	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	9.44e-06	0.000126	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—pancreatic cancer	9.41e-06	0.000126	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	9.35e-06	0.000125	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—STK11—pancreatic cancer	9.13e-06	0.000122	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	9.1e-06	0.000122	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	9.08e-06	0.000121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	9.05e-06	0.000121	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	9.02e-06	0.000121	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	8.99e-06	0.00012	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	8.93e-06	0.000119	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	8.93e-06	0.000119	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.81e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	8.8e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	8.77e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	8.71e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	8.69e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	8.68e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	8.6e-06	0.000115	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.51e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	8.48e-06	0.000113	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	8.46e-06	0.000113	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	8.4e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	8.37e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	8.37e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	8.29e-06	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	8.24e-06	0.00011	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	8.23e-06	0.00011	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	8.21e-06	0.00011	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—pancreatic cancer	8.21e-06	0.00011	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	8.2e-06	0.00011	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	8.19e-06	0.00011	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	8.16e-06	0.000109	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—pancreatic cancer	8.15e-06	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	8.13e-06	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	8.08e-06	0.000108	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	7.99e-06	0.000107	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	7.96e-06	0.000107	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—pancreatic cancer	7.94e-06	0.000106	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	7.88e-06	0.000105	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.85e-06	0.000105	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.75e-06	0.000104	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—pancreatic cancer	7.59e-06	0.000102	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	7.59e-06	0.000102	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—pancreatic cancer	7.57e-06	0.000101	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—pancreatic cancer	7.5e-06	0.0001	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	7.39e-06	9.89e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	7.37e-06	9.86e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	7.32e-06	9.79e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	7.3e-06	9.77e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	7.3e-06	9.76e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	7.3e-06	9.76e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	7.28e-06	9.74e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	7.23e-06	9.67e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	7.21e-06	9.65e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—pancreatic cancer	7.11e-06	9.51e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—pancreatic cancer	6.89e-06	9.21e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—pancreatic cancer	6.8e-06	9.1e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	6.79e-06	9.08e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—pancreatic cancer	6.78e-06	9.07e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	6.77e-06	9.05e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.75e-06	9.03e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—pancreatic cancer	6.72e-06	8.98e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	6.7e-06	8.96e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	6.7e-06	8.96e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.69e-06	8.95e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	6.65e-06	8.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	6.63e-06	8.87e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	6.57e-06	8.79e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOE—pancreatic cancer	6.39e-06	8.54e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	6.29e-06	8.41e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	6.27e-06	8.38e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	6.21e-06	8.3e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.84e-06	7.81e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	5.79e-06	7.74e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	5.78e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.76e-06	7.71e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	5.76e-06	7.7e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	5.7e-06	7.63e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—pancreatic cancer	5.62e-06	7.52e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—pancreatic cancer	5.59e-06	7.47e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—pancreatic cancer	5.57e-06	7.45e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.56e-06	7.44e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—pancreatic cancer	5.52e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	5.34e-06	7.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	5.33e-06	7.13e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	5.28e-06	7.06e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.07e-06	6.78e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	5.01e-06	6.71e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—pancreatic cancer	4.73e-06	6.33e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	4.72e-06	6.31e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	4.7e-06	6.29e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	4.66e-06	6.23e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.42e-06	5.91e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.38e-06	5.85e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.12e-06	5.51e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—pancreatic cancer	4.1e-06	5.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.82e-06	5.1e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.69e-06	3.6e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.2e-06	2.94e-05	CbGpPWpGaD
